Odyssey Therapeutics
Clinical trials sponsored by Odyssey Therapeutics, explained in plain language.
Odyssey Therapeutics
ODTX
NASDAQ
A biotechnology company developing precision medicines for cancer and autoimmune diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.